Compact Membrane Systems

United States - Wilmington, Delaware

• 02/08/2023
• Series A
• $16,500,000

Compact Membrane Systems (CMS) is on a mission to save the planet. We create technology to capture and reduce greenhouse gas emissions, avert global warming, and transform industry into a long-term sustainable enterprise. One membrane system at a time. CMS is a high-growth, advanced materials company based in Wilmington, Delaware that offers its employees personal growth, autonomy, and the opportunity to work on award-winning disruptive technology that is bringing 21st century innovation to the industrial economy. We decarbonize today’s infrastructure for a cleaner tomorrow. CMS develops and deploys new climate oriented technologies for carbon capture, renewable gas, and improvements to existing industrial processes. We live and breathe on the cutting edge of industrial technology. CMS enables large, capital intensive industrial operations to meet the needs of a changing world and a climate challenge: operating more efficiently, while also supporting the growth of new, green industries.

We are a small but mighty group of inquisitive self-starters who are passionate about learning and making a positive impact on our team-mates, colleagues, customers, and the world every day. Our individual missions and work are varied, our work culture is collaborative, and our organization is flat.

CMS operates a research facility, product development shop, and membrane manufacturing facility.

Related People

Erica NemserFounder

United States - Greater Philadelphia

At the helm of Compact Membrane Systems (CMS) and on a mission to save the planet. We create technology to capture and reduce greenhouse gas emissions, avert global warming, and transform industry into a long term sustainable enterprise. One membrane system at a time. My role has been to deliver disruptive innovation: finding and building lines of business with multi-$B potential atop the company’s talent and novel membrane separation technology (hailed as “one of the separations to change the world” in Nature Vol. 532, 2016). Along the way, I’ve been responsible for shifting the culture, mindset, and operations from a domestic science-driven R&D lab to a globally-active, commercially successful organization. Today we’re characterized by robust in-house manufacturing capabilities, continued IP generation, and delivery and support of solutions at scale to the multinational industry titans that are our customers and strategic partners.

I’m an ex-economist turned CEO/operator by way of McKinsey & Co where I was responsible for bringing organizational transformation, operational excellence and measurable commercial results to global biopharma, medical products companies, and to McKinsey itself.

I enjoy breaking down and structuring messy business problems, quickly seeing the possible future states, and charting a path through the complexity to get there. This is a double-edged sword, and I’ve learned to respect the change, time, effort and investments in people and process that it takes to bring some of these solutions to reality. I’m working to make this talent a more broadly-available force for good by coaching other up-and-coming CxOs, startup founders, and educational organizations, sharing some of the best practices and wisdom I’ve developed over the years.

LinkedIn https://www.linkedin.com/in/ericanemser/